Reema M. Vaze

Reema Vaze practices at Huntingdon Valley Surgery Center in Huntingdon Valley, Pennsylvania.

Reema Vaze's NPI, 1659863223, was assigned on May 30, 2018. Reema Vaze holds Pennsylvania license MT215579.

Reema Vaze's primary practice is Huntingdon Valley Surgery Center, at 1800 Byberry Rd, Huntingdon Valley, PA 19006 in Montgomery County. The practice phone is (215) 914-4600.

Reema Vaze's primary practice is Huntingdon Valley Surgery Center in Huntingdon Valley, Pennsylvania. Reema Vaze is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Valley Gastroenterology. Dmand AI also links Reema Vaze to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Reema Vaze practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Reema Vaze's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Reema Vaze is licensed in Pennsylvania.

CMS data shows 164 Medicare services from Reema Vaze across 5 procedure codes in 2024, for 110 Medicare patients. Medicare paid $16,152 for them.

CMS counts 110 Medicare patients who saw Reema Vaze in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Reema Vaze's median patient age at 60, with 60% women.

In 2024, Reema Vaze wrote 56 Medicare Part D claims for 24 patients. 71% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $73 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Reema Vaze accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 154 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Reema Vaze, more than 86% of the clinicians it reports for that procedure.

CMS Open Payments shows 45 general payments to Reema Vaze from 17 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $338.